Member Info for Porky9

Indeed
And so they flock in, fantastic
Materially undervalued where we are, so the only way is up... baby

We have had worse days guys....
GLA new investors and old
Pork's

Had a really lovely reply from Suzy, how good is that, a CEO that cares....
They are reviewing which platform to use and will update in due course.

I think we are going to get a detailed H1 along with a formal video presentation and Q&A session within the next few weeks. This could be the last time to be getting here in the 20p range.
GLA

Pork's

Managed to secure 98,530 @ 21.30
Real struggle, its been with HL half hour to fill !!!
Trading volumes thin, when this blows it could be material
£13.5m mcap..... go figure, just loving it
https://www.hl.co.uk/shares/shares-search-results/v/valirx-plc-ord-gbp0.001

Would like to add more but have a big commitment elsewhere i just can't not support, so its freeing up cash. Just dumped some RR. stock TBH it was going nowhere so in for a penny....

Onwards and upwards here, great start, if this breaks 25p i don't think i will be able to resist more of it...

GLA
Pork's
But this is a great

IMO we should focus on what's important and NOT get drawn into distraction techniques.
Not long to go...

Get Ready to get involved:-
https://twitter.com/NovacytGroup/status/1427181841782542343

Onwards and Upwards

@Saintsmith
“These are the people that will have wished they did a little more research and speculated more when they are paying a lot more for these shares than those who have held and accumulated more at these bargain prices”
……………………………………………………………………………………………………………………..
As quoted: -
“Be greedy when others are fearful”

I hold the firm belief that ultimately a SP must catch up with the fundamentals.

If a business is making lots of noise and hype but not delivering a bottom line, its share price will ultimately tank to that bottom line position.

Equally, if a business is delivering a solid bottom line, yet its share price has tanked, its share price will ultimately rise to match it.

Here we have Novacyt, for ease of maths let’s say £ 3.50 SP and mcap of £ 245m a PE Ratio of X1.6

Its just proven its longevity, extended NHS, two year WHO deal, solid cash at bank reserves, in practically every testing area known to man, world class bioinformatics, I could go on…

Let’s be pessimistic and say it’s going to be a £100m a year business with £ 60m EBITDA a year. (Obviously its SIGNIFICANTLY higher) and let’s say half its cash is spent on acquisitions, just go with me…

Look around the market and what do you see; peers in Diagnostics on PE Ratio between X15 and X30, just look at EKF Diagnostics (EFK) at PE X 32. Mcap £ 360m (that’s 50% higher value than where we are today on a fraction of our revenues, but it's only doing £ 65m a year and £ 15m EBITDA: -
https://www.hl.co.uk/shares/shares-search-results/e/ekf-diagnostics-holdings-plc-ord-1p

So, whilst the ill researched here and traders, ignore the fundamentals of the business and dick about trying to scrat 5% or 10% or even 20% profit here or there ultimately, we still have significantly further to go... SIGNIFICANTLY

I’m just sitting back, relaxed, and adding as funds permit. I have my long-term target and its many multiples of todays nonsense materially undervalued share price.

Day One of share price recovery towards alignment with fundamentals

GLA

Pork’s

Is it Time to Catch a Bear in a Trap?

Bears get greedy picking at an empty carcass despite there being nothing much left to gain from it
They should learn to move on but often get found lazy not following the signs

Has GM set the perfect Bear Trap?

Today is Day One of the bear trapping season at Novacyt
The scene is set, sells on Monday and Tuesday into the range highs...... Oh dear

It would be great wouldn't it....
https://tradingsim.com/blog/bear-trap-stocks/

GLA

As stated:-

It’s a really nice clean design and brings cohesion to the group, it demonstrates effectively in an instance the capability for the group across all vertical sectors. Also, it’s been designed to get information within the minimum number of clicks so its very well thought out.

SMEs to Hospitals to Travel to Oil Rigs…. Just Perfect frankly

Feedback so far via Twitter looking real positive.....

It’s a really nice clean design and brings cohesion to the group, it demonstrates effectively in an instance the capability for the group across all vertical sectors. Also, it’s been designed to get information within the minimum number of clicks so its very well thought out.

SMEs to Hospitals to Travel to Oil Rigs…. Just Perfect frankly

Venturing into a discussion tomorrow specifically for shareholders also demonstrates a step change in direction to now wanting to further engage with us, again a superb move.

Until the event completes, we can’t know yet how well it will go, but if they can effectively detail the activities ongoing, cover off the bulk of concerns it will provide not only assurances to existing shareholders but moreover act as a springboard to attract new investor and funds interest over the coming weeks as the presentation is syndicated.

Also, compared to our worldwide sector peers its possibly the cleanest and most effective design out there.

This is a win win frankly. Very positive advancement imo.

Pork's

Contacted Suzy and asked if she would consider an Investor Meets type video with Q&A

Based on conversations with other potential investors many don't really have a clue what the business is doing other than the website. She can change that and create greater SH engagement and hopefully new investor interest with it.

Appreciate they have had a challenging past and a few disgruntled Shareholders have had a tough time with dilution from placements however; it looks like this could be the turning point.

Suzy claims this will be a "Transformative Year" well it looks like that could well be the case if she can get a license deal over the line and from the current pipeline I believe that VAL301 and VAL401 have a higher-than-average chance of securing a deal. Just one of these secured in H2 and we can expect a serious break out of this 20p range.

GLA

Probably a damp squib but a bit of buying action all the same

PS -I am logging in tomorrow so if it comes up I will clarify further as requested.

With so many questions submitted they have a lot of ground to cover. I do however remain confident this could prove to be a major spring board for the business, create new interest and help drive us forwards.

Engaging with Shareholders in this way is a real positive and a first for them...

GLA

P9 means a duel listing

But lets remember this is driven by Novacyt. What we are trying to establish here is what their plans are? We are in the dark in this respect.

If they are working towards a main market listing ideally i would like them to tell us that. If they are hell bent with remaining on the Bourse ideally i want them to tell us that. A listing on the NASDAQ would create so many opportunities as it would open us up to a significantly bigger investor reach.

Getting off the bourse means reporting in one language not two another bonus.

As i say hopefully we will gain some forward vision from them - we will soon find out tomorrow
GLA

Pork's

@Harchris
Very good, if i was the next Brian Blessed, my quote would be, in loud voice Blessed fashion:-
"Oh, Fck it, shares this cheap, take as many as you can..."

Nothing to report other than an acknowledgement has been received today from Mandy:-

Dear Richard,

Thank you for the questions which will be duly considered for the investor meeting on Wednesday.

Mandy Cowling
Corporate and Investor Relations Manager
mandy.cowling@novacyt.com
Novacyt Group
www.novacyt.com
LinkedIn

@Wilson63 posted:
Porky9 perhaps a question as to why Bladesharp needs to make all announcements
https://twitter.com/Blad3sharp/status/1427235635031650307
..........................................................................................................................................

Have to say that Dean is absolutely mustard at uncovering these developments!!

I share your frustration, I recall a while back Novacyt implying that the Regulatory News Service (RNS) was only for material news that may affect the share price and not to be used as a marketing tool. However, It kind of feels like on AIM that some companies really abuse the system and release an RNS on absolutely anything. I mean, it's kind of a grey area as to what is considered material? Also, maybe the bourse rules are far stricter?

A poll on Twitter found that the majority of shareholders (those that voted) thought no further update before the meeting on Wednesday lunchtime BUT it really feels like there are a number of aspects outstanding on that we would benefit knowing about, the recently released High throughput 3G Assay and the SNPsig developed for the Mexico variant that is sweeping south of Florida feels like two of them...

Oh well guess we will all know soon enough...

Unless i'm missing something here; the company has a requirement to provide a the full unaudited results statement and trading update for the H1 before the end of September.

Last year they published it on the 7th September and the previous year it was the 26th, so I'm perplexed as to why some are complaining about an update. Appreciate its common to all stocks that shareholders want continual updates but we will have a detailed update for sure within the next few weeks. Not long to go now.

As i see it this is a golden opportunity to add at fairly cheap levels imo. If Suzy can get this right, secure some decent licensing deals a market cap 20 or 30 times where we are now is not impossible.

The company has a £ 12m value currently, crazy:-
https://www.hl.co.uk/shares/shares-search-results/v/valirx-plc-ord-gbp0.001

GLA

Porks

CHOCKS AWAY

Here's to a an exceptional and informative Shareholder meeting on Wednesday, go Novacyt....

Still Plenty of time to register to join the fun:-
https://twitter.com/NovacytGroup/status/1427181841782542343

GLA

3/3

6. Can you indicate what the manufacturing output is at IT-IS for Q16/Q32 machines and are the former Directors on target to receive their bonus based on reaching the output targets? Are you able to indicate the approximate sales value associated with Q machine sales?

7. Can you confirm the annual fees payable to ODDO. Feeling amongst the vast majority of shareholders indicates total dis-satisfaction with their appointment and their poor performance to date. As such we request their immediate removed as advisors. Will you action this request?

8. Will the board consider delisting from the Bourse and moving to the NASDAQ market? Shareholders feel you have outgrown this market and would benefit from a market with a greater reach, and it would remove the requirement of writing official updates in two languages.

9. As Graham is retiring will he still receive all his bonus from the LTIP arrangement AND when David joins is David going onto a similar LTIP scheme arrangement or a traditional share option scheme?

10. What size of contract do you consider is material enough for an RNS update and would the board commit to at least updating via RNS any contract over £ 2m?

11. M & A Question: Are you currently targeting any acquisitions and what is your timeframe for securing the next acquisition? On the flip side, have you received ANY takeover approaches for Novacyt and are you protected in anyway from a takeover due to the complication of being listed in France? Can you indicate the approximate cash at bank figure to the end of July 21? How much of this money would you wish to allocate to acquisitions?

12. When would you expect Winterplex to secure validation for sales in the US market? Can you advise where we are now with US expansion? What is the Growth rate now and expected growth rate going forward? And are there any plans to simplify the Winterplex testing process (like ProMate)? What sort of sales revenues do you think Winterplex can achieve? Also, when do you expect the Saliva Test to secure Validation in the UK. Also, have the Antigen LFT products gone into production yet? What did Graham mean by Sales could be “Significant”?

2/3

1. We appreciate that you can’t divulge specifics regarding the DHSC debacle BUT can you at least tell us how long the ADR process is likely last? Are you working to any timelines? Do you have a resolution date ideally you would like this concluded by? Also, who is the chief negotiator facing off against DHSC (excluding lawyer) additionally is the incoming CEO in agreement with the replacement goods figures told to shareholders and does he too believe the dispute will be settled in Novacyts favour? If the incoming CEO intends to adopt a different strategy when will shareholders be informed?

2. Can you confirm what Novacyt are planning for the future in Oncology. Whilst Covid is clearly the priority of the moment, longer term what is your view for the future, in terms of enabling quicker, more accurate diagnosis and tailored individual specific treatments and tests developed relating to transplants. Also, what percentage of your R & D teamwork relates to non covid products?

3. What steps are you taking to improve shareholder communication going forwards? Will you update your website and bring cohesion to your brands? Will you switch off comments in Twitter on your company page.

4. Shareholders believe that contributing to your lower valuation is the belief that demand for Covid testing will end abruptly and your business will return to pre Covid revenues. Can we now say with some certainty that Covid testing at a relatively high level is likely to persist into at least your 2023 financial Year and you are now better positioned for other revenue streams. Has the growth from Covid testing put you on the path for aggressive future growth? Also, regarding the future diagnostics landscape, what opportunities are there now going forward that there weren't pre pandemic.

5. The share price has collapsed from over £12 to under £3. Do you have a game plan to help restore value for investors owning shares at the higher prices and for restoring investor confidence in general?

1/3

Dear Graham,

I write on behalf of numerous shareholders on London South East discussion board (LSE) and Twitter shareholder followers.

Due to time constraints during the meeting and the large number of questions submitted, we all appreciate that it is unlikely you will be able to cover off all the queries and concerns of your shareholders. Would you therefore, consider posting responses in writing to all the unanswered questions on the Novacyt website after the meeting?

In the meantime, the following questions represent the top 12 questions that shareholders desperately feel are the most essential that we require answers on during the discussion. Can you please ensure that these 12 questions at the very least are fully answered and given priority?

We thank you in advance and congratulate you on organising this amazing event and opportunity for greater direct shareholder engagement.

Further, we would like to thank you for your commitment to the Business and wish you a most enjoyable retirement.

Essential Questions List: